RN1201

· The First Affiliated Hospital with Nanjing Medical University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RN1201, covering 2025-07-18 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies [Phase 1]